According to Avid Bioservices 's latest financial reports the company's current revenue (TTM) is $0.14 B. In 2022 the company made a revenue of $0.13 B an increase over the years 2021 revenue that were of $0.10 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.14 B | 5.03% |
2022 | $0.13 B | 26.26% |
2021 | $0.10 B | 46.4% |
2020 | $72.59 M | 12.71% |
2019 | $64.4 M | 76.31% |
2018 | $36.52 M | -46.68% |
2017 | $68.51 M | 25.77% |
2016 | $54.47 M | 59.37% |
2015 | $34.17 M | 54.27% |
2014 | $22.15 M | -5.06% |
2013 | $23.33 M | 48.29% |
2012 | $15.73 M | 1.53% |
2011 | $15.49 M | -30.11% |
2010 | $22.17 M | -21.74% |
2009 | $28.33 M | 369.66% |
2008 | $6.03 M | -1.41% |
2007 | $6.12 M | 73.17% |
2006 | $3.53 M | 16.4% |
2005 | $3.03 M | -36.37% |
2004 | $4.77 M | 17.63% |
2003 | $4.05 M | 151.77% |
2002 | $1.61 M | -59.41% |
2001 | $3.96 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Neogen NEOG | $0.92 B | 559.32% | ๐บ๐ธ USA |
Natera NTRA | $1.08 B | 668.12% | ๐บ๐ธ USA |